triiodothyronine has been researched along with Hyperglycemia in 29 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol treatment reversed thyroxin induced hypertriglyceridemia, whereas propranolol treatment had no effect." | 5.34 | Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study. ( Bhatt, P; Goyal, R; Makwana, D; Santani, D, 2007) |
| " Several major conclusions are justified from the data obtained: (1) Although the hepatic specific activity of fatty acid synthetase is higher in obese than in non obese animals pair-fed chow, no difference in hepatic activities is apparent in animals pair-fed the fat-free diet; (2) The higher enzymatic activity in obese animals fed chow is related to a higher content of enzyme, and this higher content is associated with a higher rate of enzyme synthesis; (3) The decrease in hepatic synthetase activity with starvation is distinctly more striking in non obese than in obese animals, and the changes in activity reflect changes in content of enzyme; (4) With starvation there is a decrease in synthesis of enzyme in obese and non obese animals, but only in non obese animals is there also a marked increase in the rate of synthetase degradation (t1/2 = 24 h during starvation, t1/2 = 76 h during normalfeeding); (5) Refeeding starved mice a fat-free diet results in a more striking increase in hepatic synthetase activity in non obese than in obese animals; (6) Administration of triiodothyronine causes a more marked increase in hepatic synthetase activity in non obese than in obese animals." | 3.65 | Regulation of hepatic fatty acid synthetase in the obese-hyperglycemic mutant mouse. ( Marasa, JC; Volpe, JJ, 1975) |
| "Critical illness is often associated with reduced TSH and thyroid hormone secretion as well as marked changes in peripheral thyroid hormone metabolism, resulting in low serum T(3) and high rT(3) levels." | 2.71 | Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. ( Kaptein, E; Peeters, RP; Van den Berghe, G; van Toor, H; Visser, TJ; Wouters, PJ, 2003) |
| "After treatment for myxedema with liothyronine 5 mcg two times per day and levothyroxine 175 mcg once daily via a nasogastric tube and diabetic ketoacidosis with intravenously administered fluid and insulin, his clinical condition rapidly improved including mental status, hyperglycemia, and acidosis." | 1.51 | Myxedema coma precipitated by diabetic ketoacidosis after total thyroidectomy: a case report. ( Kim, EY; Kim, JJ, 2019) |
| "It seems that hyperglycemia is not an important risk factor for future diabetes." | 1.38 | Thyroid function and stress hormones in children with stress hyperglycemia. ( Bordbar, MR; Haghpanah, S; Karamizadeh, Z; Karimi, M; Omrani, GH; Taj-Aldini, R, 2012) |
| "Notably, diabetic nephropathy was accompanied by a significant decrease in PI3K activity and an increase in TGF-β1 expression in kidneys." | 1.37 | Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes. ( Lin, Y; Sun, Z, 2011) |
| "Carvedilol treatment reversed thyroxin induced hypertriglyceridemia, whereas propranolol treatment had no effect." | 1.34 | Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study. ( Bhatt, P; Goyal, R; Makwana, D; Santani, D, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (37.93) | 18.7374 |
| 1990's | 4 (13.79) | 18.2507 |
| 2000's | 5 (17.24) | 29.6817 |
| 2010's | 9 (31.03) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katz, LS | 1 |
| Xu, S | 1 |
| Ge, K | 1 |
| Scott, DK | 1 |
| Gershengorn, MC | 1 |
| Kamrul-Hasan, M | 1 |
| Siddiqui, NI | 1 |
| Shubha, RA | 1 |
| Abu-Bakar, M | 1 |
| Chanda, PK | 1 |
| Haque, FI | 1 |
| Kim, JJ | 1 |
| Kim, EY | 1 |
| Finan, B | 1 |
| Clemmensen, C | 1 |
| Zhu, Z | 1 |
| Stemmer, K | 1 |
| Gauthier, K | 1 |
| Müller, L | 1 |
| De Angelis, M | 1 |
| Moreth, K | 1 |
| Neff, F | 1 |
| Perez-Tilve, D | 1 |
| Fischer, K | 1 |
| Lutter, D | 1 |
| Sánchez-Garrido, MA | 1 |
| Liu, P | 1 |
| Tuckermann, J | 1 |
| Malehmir, M | 1 |
| Healy, ME | 1 |
| Weber, A | 1 |
| Heikenwalder, M | 1 |
| Jastroch, M | 1 |
| Kleinert, M | 1 |
| Jall, S | 1 |
| Brandt, S | 1 |
| Flamant, F | 1 |
| Schramm, KW | 1 |
| Biebermann, H | 1 |
| Döring, Y | 1 |
| Weber, C | 1 |
| Habegger, KM | 1 |
| Keuper, M | 1 |
| Gelfanov, V | 1 |
| Liu, F | 1 |
| Köhrle, J | 1 |
| Rozman, J | 1 |
| Fuchs, H | 1 |
| Gailus-Durner, V | 1 |
| Hrabě de Angelis, M | 1 |
| Hofmann, SM | 1 |
| Yang, B | 1 |
| Tschöp, MH | 1 |
| DiMarchi, R | 1 |
| Müller, TD | 1 |
| Parmar, HS | 1 |
| Kar, A | 2 |
| Derde, S | 1 |
| Vanhorebeek, I | 1 |
| Ververs, EJ | 1 |
| Vanhees, I | 1 |
| Darras, VM | 1 |
| Van Herck, E | 1 |
| Larsson, L | 1 |
| Van den Berghe, G | 2 |
| Lin, Y | 2 |
| Sun, Z | 2 |
| Bordbar, MR | 1 |
| Taj-Aldini, R | 1 |
| Karamizadeh, Z | 1 |
| Haghpanah, S | 1 |
| Karimi, M | 1 |
| Omrani, GH | 1 |
| Matsen, ME | 1 |
| Thaler, JP | 1 |
| Wisse, BE | 1 |
| Guyenet, SJ | 1 |
| Meek, TH | 1 |
| Ogimoto, K | 1 |
| Cubelo, A | 1 |
| Fischer, JD | 1 |
| Kaiyala, KJ | 1 |
| Schwartz, MW | 1 |
| Morton, GJ | 1 |
| Peeters, RP | 1 |
| Wouters, PJ | 1 |
| Kaptein, E | 1 |
| van Toor, H | 1 |
| Visser, TJ | 1 |
| KELLEN, J | 1 |
| Szkudelski, T | 1 |
| Michalski, W | 1 |
| Szkudelska, K | 1 |
| Jatwa, R | 1 |
| Bhatt, P | 1 |
| Makwana, D | 1 |
| Santani, D | 1 |
| Goyal, R | 1 |
| Alexander, CM | 1 |
| Lum, SM | 1 |
| Rhodes, J | 1 |
| Boarman, C | 1 |
| Nicoloff, JT | 1 |
| Kumar, D | 1 |
| Achmadi, J | 1 |
| Terashima, Y | 1 |
| Chapa, AM | 1 |
| Fernandez, JM | 1 |
| Thompson, DL | 1 |
| Tempelman, RJ | 1 |
| Berrio, LF | 1 |
| Croom, WJ | 1 |
| Hagler, WM | 1 |
| Shimokawa, T | 1 |
| Kato, M | 1 |
| Shioduka, K | 1 |
| Irie, J | 1 |
| Ezaki, O | 1 |
| Garthwaite, TL | 1 |
| Kalkhoff, RK | 1 |
| Guansing, AR | 1 |
| Hagen, TC | 1 |
| Menahan, LA | 1 |
| Blichert-Toft, M | 1 |
| Christensen, V | 1 |
| Engquist, A | 1 |
| Fog-Moller, F | 1 |
| Kehlet, H | 1 |
| Madsen, SN | 1 |
| Skovsted, L | 1 |
| Thode, J | 1 |
| Olgaard, K | 1 |
| Hall, R | 1 |
| Gomez-Pan, A | 1 |
| Volpe, JJ | 1 |
| Marasa, JC | 1 |
| Wronska, D | 1 |
| Niezgoda, J | 1 |
| Sechman, A | 1 |
| Bobek, S | 1 |
| Röjdmark, S | 1 |
| Berg, A | 1 |
| Ekström, U | 1 |
| Ikeda, T | 1 |
| Takeuchi, T | 1 |
| Ito, Y | 1 |
| Murakami, I | 1 |
| Mokuda, O | 1 |
| Tominaga, M | 1 |
| Mashiba, H | 1 |
| Mohamed, HF | 1 |
| Ageel, AM | 1 |
| el-Denshary, ES | 1 |
| Abu-Jayyab, AR | 1 |
| el-Wakkad, I | 1 |
| Gharib, H | 1 |
| Munoz, JM | 1 |
| Vinik, A | 1 |
| Pimstone, B | 1 |
| Buchanan-Lee, B | 1 |
1 review available for triiodothyronine and Hyperglycemia
| Article | Year |
|---|---|
The hypothalamic regulatory hormones and their clinical applications.
Topics: Female; Follicle Stimulating Hormone; Gastrins; Glucagon; Gonadotropin-Releasing Hormone; Humans; Hy | 1976 |
1 trial available for triiodothyronine and Hyperglycemia
| Article | Year |
|---|---|
Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients.
Topics: Aged; Aged, 80 and over; Biopsy; Critical Illness; Humans; Hyperglycemia; Hypoglycemic Agents; Insul | 2003 |
27 other studies available for triiodothyronine and Hyperglycemia
| Article | Year |
|---|---|
T3 and Glucose Coordinately Stimulate ChREBP-Mediated Ucp1 Expression in Brown Adipocytes From Male Mice.
Topics: Active Transport, Cell Nucleus; Adipocytes, Brown; Adipogenesis; Animals; Basic Helix-Loop-Helix Leu | 2018 |
Low Free T₃ was Associated with Poor Glycemic Control in Type 2 Diabetes in a Hospital Based Study in Bangladesh.
Topics: Adult; Bangladesh; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia | 2018 |
Myxedema coma precipitated by diabetic ketoacidosis after total thyroidectomy: a case report.
Topics: Adult; Blood Gas Analysis; Coma; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Glycated Hemoglob | 2019 |
Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.
Topics: Animals; Atherosclerosis; Body Weight; Bone and Bones; Chemical Engineering; Cholesterol; Diabetes M | 2016 |
Possible amelioration of atherogenic diet induced dyslipidemia, hypothyroidism and hyperglycemia by the peel extracts of Mangifera indica, Cucumis melo and Citrullus vulgaris fruits in rats.
Topics: Animals; Ascorbic Acid; Atherosclerosis; Blood Glucose; Citrullus; Creatine Kinase, MB Form; Cucumis | 2008 |
Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits.
Topics: Actins; Animals; Blood Glucose; Body Weight; Critical Illness; Disease Models, Animal; Glucose; Hype | 2010 |
Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Basic Helix-Loop-Helix Transcription Factors; Blood Glucose; Bloo | 2011 |
Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
Topics: Albuminuria; Animals; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic | 2011 |
Thyroid function and stress hormones in children with stress hyperglycemia.
Topics: Adolescent; Aging; Child; Child, Preschool; Cross-Sectional Studies; Female; Hormones; Human Growth | 2012 |
In uncontrolled diabetes, thyroid hormone and sympathetic activators induce thermogenesis without increasing glucose uptake in brown adipose tissue.
Topics: Acetates; Adipose Tissue, Brown; Adrenergic beta-3 Receptor Agonists; Animals; Body Composition; Dia | 2013 |
[The "rebound phenomenon" in fat metabolism after triiodothyronine].
Topics: Fats; Humans; Hyperglycemia; Lipid Metabolism; Triiodothyronine | 1960 |
The effect of thyroid hormones on blood insulin level and metabolic parameters in diabetic rats.
Topics: Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Energy Metabolism; Hyperglycemia; | 2003 |
Cardio-protective role of terazosin is possibly mediated through alteration in thyroid function.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Glucose; Cholesterol, Dietary; Disease Models, Animal; | 2006 |
Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
Topics: Adrenergic beta-Antagonists; Animals; Appetite; Blood Glucose; Blood Pressure; Body Mass Index; Body | 2007 |
Rapid increase in both plasma fibronectin and serum triiodothyromine associated with treatment of diabetic ketoacidosis.
Topics: Adult; Diabetic Ketoacidosis; Female; Fibronectins; Humans; Hyperglycemia; Insulin; Kinetics; Male; | 1983 |
The effect of propylthiouracyl-induced low thyroid function on secretion response and action of insulin in sheep.
Topics: Animals; Blood Glucose; Female; Glucose; Glucose Clamp Technique; Hyperglycemia; Hypothyroidism; Ins | 1995 |
Endocrine and metabolic response to muscarinic stimulation and inhibition in the ruminant: effects of slaframine.
Topics: Alkaloids; Animals; Blood Glucose; Endocrine Glands; Fatty Acids, Nonesterified; Female; Goat Diseas | 1995 |
Effect of triiodothyronine on muscle cell differentiation and blood glucose level in hyperglycemic KK mice.
Topics: Animals; Biomarkers; Blood Glucose; Body Weight; Cell Differentiation; Diabetes Mellitus, Type 2; Gl | 1997 |
Plasma free tryptophan, brain serotonin, and an endocrine profile of the genetically obese hyperglycemic mouse at 4--5 months of age.
Topics: Adrenocorticotropic Hormone; Animals; Blood Glucose; Brain; Fasting; Glucagon; Hormones; Hyperglycem | 1979 |
Influence of age on the endocrine-metabolic response to surgery.
Topics: Adult; Age Factors; Aged; Aldosterone; Anesthesia, General; Electrolytes; Endocrine Glands; Hernia, | 1979 |
Regulation of hepatic fatty acid synthetase in the obese-hyperglycemic mutant mouse.
Topics: Animals; Fatty Acid Synthases; Half-Life; Hyperglycemia; Liver; Mice; Mice, Inbred C57BL; Mice, Obes | 1975 |
Food deprivation suppresses stress-induced rise in catabolic hormones with a concomitant tendency to potentiate the increment of blood glucose.
Topics: Animals; Blood Glucose; Female; Food Deprivation; Hormones; Hydrocortisone; Hyperglycemia; Sheep; St | 1990 |
Hormone release from thyrotrophs and lactotrophs during hypo- and hyperglycemia.
Topics: Adult; Female; Humans; Hyperglycemia; Hypoglycemia; Insulin; Male; Pituitary Gland, Anterior; Prolac | 1989 |
Effect of hyperglycemia on serum T4 and T3 levels in rats.
Topics: Animals; Glucose; Hyperglycemia; Infusions, Intravenous; Male; Rats; Rats, Inbred Strains; Thyroxine | 1987 |
Mechanism of bromocriptine-induced hyperglycaemia.
Topics: Adrenalectomy; Animals; Bromocriptine; Corticosterone; Hyperglycemia; Insulin; Liver Glycogen; Male; | 1985 |
Endocrine manifestations of diphenylhydantoin therapy.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Alkaline Phosphatase; Blood Glucose; End | 1974 |
Impairment of hyperglycemic induced growth hormone suppression in hyperthyroidism.
Topics: Blood Glucose; Catecholamines; Growth Hormone; Humans; Hyperglycemia; Hyperthyroidism; Hypothalamo-H | 1968 |